Date: 12 Mar 2011
The pharmacology of preventing Preeclampsia
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
- Steegers EA, von Dadelszen P, Duvekot JJ, et al. Lancet 2010;376:631–644. CrossRef
- Sibai B, Dekker G, Kupferminc M. Preeclampsia. Lancet 2005;365:785–799.
- World Health Organization International Collaborative Study of Hypertensive Disorders of Pregnancy. Geographic variation in the incidence of hypertension in pregnancy. Am J Obstet Gynecol 1988;158: 80–83.
- Khan KS, Wojdyla D, Say L, et al. WHO analysis of causes of maternal death: a systematic review. Lancet 2006;367:1066–1074. CrossRef
- Cnossen JS, ter Riet G, Mol BW, et al. Are tests for predicting pre-eclampsia good enough to make screening viable? A review of reviews and critical appraisal. Acta Obstet Gynecol Scand 2009;88:758–765. CrossRef
- Villamor E, Cnattingius S. Interpregnancy weight change and risk of adverse pregnancy outcomes: a population-based study. Lancet 2006;368:1164–1170. CrossRef
- Jim B, Sharma S, Kebede T, Acharya A. Hypertension in pregnancy: a comprehensive update. Cardiol Rev 2010;18:178–189. CrossRef
- Nadar S, Lip GY. Platelet activation in the hypertensive disorders of pregnancy. Expert Opin Investig Drugs 2004;13:523–529. CrossRef
- Stillman IE, Karumanchi SA. The glomerular injury of preeclampsia. J Am Soc Nephrol 2007;18:2281–2284. CrossRef
- Irani RA, Xia Y. The functional role of the reninangiotensin system in pregnancy and preeclampsia. Placenta 2008;29:763–771. CrossRef
- Vane JR, Botting RM. The mechanism of action of aspirin. Thromb Res 2003;110:255–258. CrossRef
- Dekker GA, Sibai BM. Low-dose aspirin in the prevention of preeclampsia and fetal growth retardation: rationale, mechanisms and clinical trials. Am J Obstet Gynecol 1993;168:214–227.
- Marret S, Marchand L, Kaminski M, et al. EPIPAGE Study Group. Prenatal low-dose aspirin and neurobehavioral outcomes of children born very preterm. Pediatrics.2010;125:29–34. CrossRef
- Norgard B, Puho E, Czeizel AE, et al. Aspirin use during early pregnancy and the risk of congenital abnormalities: a population-based case-control study. Am J Obstet Gynecol 2005;192:922–923. CrossRef
- Askie LM, Duley L, Henderson-Smart DJ, et al. PARIS Collaborative Group. Antiplatelet agents for prevention of preeclampsia: A meta-analysis of individual patient data. Lancet 2007;369:1791–1798. CrossRef
- Gupta S, Aziz N, Sekhon L, et al. Lipid peroxidation and antioxidant status in preeclampsia: a systematic review. Obstet Gynecol Surv 2009;64:750–759. CrossRef
- Saeed SA, Mitchell MD. Conversion of arachidonic acid to lipoxygenase products by human fetal tissues. Biochem Med 1983;30:322–327. CrossRef
- Spinnato JA, Livingston JC. Prevention of preeclampsia with antioxidants: Evidence from randomized trials. Clinical Obstet Gynecol 2005;48:416–429. CrossRef
- Hofmeyr GJ, Lawrie TA, Atallah AN, et al. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database Syst Rev. 2010;(8):CD001059.
- Trumbo PR, Ellwood KC. Supplemental calcium and risk reduction of hypertension, pregnancy-induced hypertension, and preeclampsia: an evidence-based review by the US Food and Drug Administration. Nutr Rev 2007;65:78–87. CrossRef
- Chappell LC, Seed PT, Briley AL, et al. Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomized trial. Lancet 1999;354:810–816.
- Roberts JM, Myatt L, Spong CY, et al. Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Vitamins C and E to prevent complications of pregnancy-associated hypertension. N Engl J Med 2010;362:1282–1291. CrossRef
- Villar J, Purwar M, Merialdi M, et al. WHO randomised trial of vitamin C & E supplementation among women at high risk for preeclampsia and nutritional deficiency. Am J Obset Gynecol 2007;197:S4. CrossRef
- McCance DR, Holmes VA, Maresh MJ, et al. Diabetes and Pre-eclampsia Intervention Trial (DAPIT) Study Group. Vitamins C and E for prevention of pre-eclampsia in women with type 1 diabetes (DAPIT): a randomised placebo-controlled trial. Lancet 2010;376:259–266. CrossRef
- Poston L, Briley AL, Seed PT, et al. Vitamins in Pre-eclampsia (VIP) Trial Consortium. Vitamin C and vitamin E in pregnant women at risk for preeclampsia (VIP trial): randomised placebo-controlled trial. Lancet 2006;367:1145–1154. CrossRef
- Branch DW, Silver RM, Porter TF. Obstetric antiphospholipid syndrome: current uncertainties should guide our way. Lupus 2010;19:446–452. CrossRef
- Olsen SF, Secher NJ, Tabor A, et al. Randomised clinical trials of fish oil supplementation in high risk pregnancies. Fish Oil Trials in Pregnancy (FOTIP) Team. BJOG 2000;107:382–395. CrossRef
- Olafsdottir AS, Skuladottir GV, Thorsdottir I, et al. Relationship between high consumption of marine fatty acids in early pregnancy and hypertensive disorders in pregnancy. BJOG 2006;113:301–309. CrossRef
- Meher S, Duley L. Nitric oxide for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev 2007;(2):CD006490.
- Meher S, Duley L. Progesterone for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev 2006;(4):CD006175.
- The pharmacology of preventing Preeclampsia
The Journal of Obstetrics and Gynecology of India
Volume 60, Issue 6 , pp 486-493
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links